ARCHIVES

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014